Tumor-promoting functions of adenosine

Pharmacology and Therapeutics

Volumn 87, Issue 2-3, 2000, Pages 161-173

  Spychala, Jozef ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

5' Nucleotidase; Adenosine; Angiogenesis; Multidrug resistance; Tumor immunity; Tumor promotion

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE KINASE; ECTO 5' NUCLEOTIDASE;

CANCER RESISTANCE; CELL PROTECTION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CYTOKINE PRODUCTION; HUMAN; IMMUNE DEFICIENCY; LEUKOCYTE ADHERENCE; LYMPHOCYTE FUNCTION; MACROPHAGE FUNCTION; METASTASIS; MULTIDRUG RESISTANCE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; TISSUE LEVEL; TUMOR GROWTH; TUMOR IMMUNOLOGY; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

5'-NUCLEOTIDASE; ADENOSINE; CELL ADHESION; CYTOKINES; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMAN; IMMUNITY, CELLULAR; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0033796779     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(00)00053-X     Document Type: Conference Paper

References (193)

1. Abraham E.H., Prat A.G., Gerweck L., Seneveratne T., Arceci R.J., Kramer R., Guidotti G., Cantiello H.F. The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc Natl Acad Sci USA. 90:1993;312-316.
2. Airas L., Jalkanen S. CD73 mediates adhesion of B cells to follicular dendritic cells. Blood. 88:1996;1755-1764.
3. Airas L., Hellman J., Salmi M., Bono P., Puurunen T., Smith D.J., Jalkanen S. CD73 is involved in lymphocyte binding to the endothelium. characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73 J Exp Med. 182:1995;1603-1608.
4. Airas L., Niemela J., Salmi M., Puurunen T., Smith D.J., Jalkanen S. Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells. J Cell Biol. 136:1997;421-431.
5. Anastassiou E.D., Paliogianni F., Balow J.P., Yamada H., Boumpas D.T. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels. J Immunol. 148:1992;2845-2852.
6. Apasov S.G., Sitkovsky M.V. The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase. Int Immunol. 11:1998;179-189.
7. Arch J.R.S., Newsholm E.A. The control of the metabolism and the hormonal role of adenosine. Essays Biochem. 14:1978;82-123.
8. Armstrong M.A., Shah S., Hawkins S.A., Bell A.L., Roberts D.S. Reduction of monocyte 5′-nucleotidase activity by gamma-interferon in multiple sclerosis and autoimmune diseases. Ann Neurol. 24:1988;12-16.
9. Averill L.E., Stein R.L., Kammer G.M. Control of human T-lymphocyte interleukin-2 production by a cAMP-dependent pathway. Cell Immunol. 115:1988;88-99.
10. Balis M.E. Adenosine deaminase and malignant cells. Ann N Y Acad Sci. 451:1985;142-149.
11. Barankiewicz J., Cohen A. Extracellular ATP metabolism in B and T lymphocytes. Ann N Y Acad Sci. 603:1990;380-392.
12. Barankiewicz J., Danks A.M., Abushanab E., Makings L., Wieman T., Wallis R.A., Pragnachayurulu P.V., Fox A., Marangos P.J. Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors. J Pharmacol Exp Ther. 283:1997;1230-1238.
13. Barcz E., Sommer E., Sokolnicka I., Gawrychowski K., Roszkowska-Purska K., Janik P., Skopinska-Rozewska E. The influence of theobromine on angiogenic activity and proangiogenic cytokines production of human ovarian cancer cells. Oncol Rep. 5:1998;517-520.
14. Bardot V., Dutrillaux A.M., Delattre J.Y., Vega F., Poisson M., Dutrillaux B., Luccioni C. Purine and pyrimidine metabolism in human gliomas. relation to chromosomal aberrations Br J Cancer. 70:1994;212-218.
15. Belardinelli L., Shryock J.C. Does adenosine function as a retaliatory metabolite in the heart? News Physiol Sci. 7:1992;52-56.
16. Belardinelli L., Linden J., Berne R.M. The cardiac effects of adenosine. Prog Cardiovasc Dis. 32:1989;73-97.
17. Berne R.M. Cardiac nucleotides in hypoxia. possible role in regulation of coronary blood flow Am J Physiol. 204:1963;317-322.
18. Birch R.E., Polmar S.H. Adenosine induced immunosuppression. the role of the adenosine receptor-adenylate cyclase interaction in the alteration of T-lymphocyte surface phenotype and immunoregulatory function Int J Immunopharmacol. 8:1986;329-337.
19. Blackburn M.R., Xiang G., Airhart M.J., Skalko R.G., Thompson L.F., Knudsen T.B. Adenosine levels in the postimplantation mouse uterus - quantitation by HPLC-fluorometric detection and spatiotemporal regulation by 5′-nucleotidase and adenosine deaminase. Dev Dyn. 194:1992;155-168.
20. Bodin P., Burnstock G. Synergistic effect of acute hypoxia on flow-induced release of ATP from cultured endothelial cells. Experientia. 51:1995;256-259.
21. Bodin P., Burnstock G. ATP-stimulated release of ATP by human endothelial cells. J Cardiovasc Pharmacol. 27:1996;872-875.
22. Bogenrieder T., Finstad C., Freeman R., Papandreou C., Scher H., Albino A., Reuter V., Nanus D. Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue. Prostate. 33:1997;225-232.
23. Bontemps F., Van den Berghe G., Hers H.-G. Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes. Proc Natl Acad Sci USA. 80:1983;2829-2833.
24. Bouma M.G., Stad R.K., van den Wildenberg F.A., Buurman W.A. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol. 153:1994;4159-4168.
25. Bouma M.G., van den Wildenberg F.A., Buurman W.A. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol. 270:1996;C522-C529.
26. Bouma M.G., Jeunhomme T.M., Boyle D.L., Dentener M.A., Voitenok N.N., van den Wildenberg F.A., Buurman W.A. Adenosine inhibits neutrophil degranulation in activated human whole blood. involvement of adenosine A2 and A3 receptors J Immunol. 158:1997;5400-5408.
27. Braun N., Zimmermann H. Association of ecto-5′-nucleotidase with specific cell types in the adult and developing rat olfactory organ. J Comp Neurol. 393:1998;528-537.
28. Braun N., Brendel P., Zimmermann H. Distribution of 5′-nucleotidase in the developing mouse retina. Dev Brain Res. 88:1995;79-86.
29. Braun N., Lenz C., Gillardon F., Zimmermann M., Zimmermann H. Focal cerebral ischemia enhances glial expression of ecto-5′-nucleotidase. Brain Res. 766:1997;213-226.
30. Braun N., Zhu Y., Krieglstein J., Culmsee C., Zimmermann H. Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J Neurosci. 18:1998;4891-4900.
31. Bui T.D., Rankin J., Smith K., Huguet E.L., Ruben S., Strachan T., Harris A.L., Lindsay S. A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas. Oncogene. 14:1997;1249-1253.
32. Caldwell C.C., Davis M.D., Knowles A.F. Ectonucleotidases of avian gizzard smooth muscle and liver plasma membranes. a comparative study Arch Biochem Biophys. 362:1999;46-58.
33. Canbolat O., Durak I., Cetin R., Kavutcu M., Demirci S., Ozturk S. Activities of adenosine deaminase, 5′-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues. Breast Cancer Res Treat. 37:1996;189-193.
34. Cetinkale O., Bilgic L., Ayan F., Kandilci A. Neutrophil-mediated injury in ischemic skin flaps. amelioration of ischemic injury by cyclosporine in the rat Ann Plast Surg. 37:1996;66-74.
35. Chadwick B.P., Frischauf A.M. The CD39-like gene family. identification of three new human members (CD39L2, CD39L3, and CD39L4), their murine homologues, and a member of the gene family from Drosophila melanogaster Genomics. 50:1998;357-367.
36. Che M., Gatmaitan Z., Arias I.M. Ectonucleotidases, purine nucleoside transporter, and function of the bile canalicular plasma membrane of the hepatocyte. FASEB J. 11:1997;101-108.
37. Cho-Chung Y.S., Clair T., Tortora G., Yokozaki H. Role of site-selective cAMP analogs in the control and reversal of malignancy. Pharmacol Ther. 50:1991;1-33.
38. Christensen L.D., Andersen V., Nygaard P., Bendtzen K. Effects of immunomodulators on ecto-5′-nucleotidase activity on blood mononuclear cells in vitro. Scand J Immunol. 35:1992;407-413.
39. Clark C.M., Goodland G.A. Protein and enzyme content of plasma membranes derived from Walker 256 carcinoma cells grown as ascitic or solid tumors. Cancer Lett. 68:1993;91-94.
40. Corradetti R., Conte L.G., Moroni F., Passani M.B., Pepeu G. Adenosine decreases glutamate and aspartate release from rat hippocampal slices. Eur J Pharmacol. 104:1984;19-26.
41. Cotrina M.L., Lin J.H., Alves-Rodrigues A., Liu S., Li J., Azmi-Ghadimi H., Kang J., Naus C.C., Nedergaard M. Connexins regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci USA. 95:1998;15735-15740.
42. Coventry B.J., Weeks S.C., Heckford S.E., Sykes P.J., Bradley J., Skinner J.M. Lack of IL-2 expression despite IL-2 messenger RNA transcription in tumor infiltrating lymphocytes in primary human breast carcinoma. selective expression of early activation markers J Immunol. 156:1996;3486-3492.
43. Cronstein B.N. Molecular mechanism of methotrexate action in inflammation. Inflammation. 16:1992;411-423.
44. Cronstein B.N., Rosenstein E.D., Kramer S.B., Weissmann G., Hirschhorn R. Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol. 135:1985;1366-1371.
45. 2) release by activated human neutrophils. Clin Immunol Immunopathol. 42:1987;76-85.
46. Cronstein B.N., Eberle M.A., Gruber H.E., Levin R.I. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA. 88:1991;2441-2445.
47. Cronstein B.N., Naime D., Firestein G. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum. 38:1995;1040-1045.
48. Cronstein B.N., Montesinos M.C., Weissmann G. Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFκB. Proc Natl Acad Sci USA. 96:1999;6377-6381.
49. Dang N., Torimoto Y., Deusch K., Schlossman S., Morimoto C. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. J Immunol. 144:1990;4092-4100.
50. Dasmahapatra K.S., Hill H.Z., Dasmahapatra A., Suarez S. Evaluation of adenosine deaminase activity in patients with head and neck cancer. J Surg Res. 40:1986;368-373.
51. Decking U.K.M., Schlieper G., Kroll K., Schrader J. Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release. Circ Res. 8:1997;154-164.
52. Delaney S.M., Geiger J.D. Levels of endogenous adenosine in rat striatum. II. Regulation of basal and N-methyl-D-aspartate-induced levels by inhibitors of adenosine transport and metabolism. J Pharmacol Exp Ther. 285:1998;568-572.
53. Dinjens W.N., Ten Kate J., Kirch J.A., Tanke H.J., Van der Linden E.P., Van den Ingh H.F., Van Steenbrugge G.J., Meera Khan P., Bosman F.T. Adenosine deaminase complexing protein (ADCP) expression and metastatic potential in prostatic adenocarcinomas. J Pathol. 160:1990;195-201.
54. Di Palo F.Q., Rivolta R., Elli A., Castagnone D., Palazzi P., Abelli P., Zafiropulu S., Zanussi C. Effect of cyclosporin A on renal cortical resistances measured by color doppler flowmetry on renal grafts. Nephron. 65:1993;240-244.
55. Dong R.P., Kameoka J., Hegen M., Tanaka T., Xu Y., Schlossman S.F., Morimoto C. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol. 156:1996;1349-1355.
56. Dornand J., Bonnafous J.C., Favero J., Mani J.C. Ecto-5′nucleotidase and adenosine deaminase activities of lymphoid cells. Biochem Med. 28:1982;144-156.
57. Dunwiddie T.V., Diao L. Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses. J Pharmacol Exp Ther. 268:1994;537-545.
58. Durak I., Cetin R., Canbolat O., Cetin D., Yurtarslani Z., Unal A. Adenosine deaminase, 5′-nucleotidase, guanase and cytidine deaminase activities in gastric tissues from patients with gastric cancer. Cancer Lett. 84:1994;199-202. a.
59. Durak I., Perk H., Kavutcu M., Canbolat O., Akyol O., Beduk Y. Adenosine deaminase, 5′-nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in cancerous and noncancerous human bladder tissues. Free Radic Biol Med. 16:1994;825-831. b.
60. Durak I., Beduk Y., Kavutcu M., Suzer O., Yaman O., Ozturk H.S., Canbolat O., Ulutepe S. Activity of the enzymes participating in purine metabolism of cancerous and noncancerous human kidney tissues. Cancer Invest. 15:1997;212-216.
61. Dusseau J.W., Hutchins P.M. Hypoxia-induced angiogenesis in chick chorioallantoic membranes. a role for adenosine Respir Physiol. 71:1988;33-44.
62. Dzhandzhugazyan K.N., Kirkin A.F., thor Straten P., Zeuthen J. Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas. FEBS Lett. 430:1998;227-230.
63. Eigler A., Greten T.F., Sinha B., Haslberger C., Sullivan G.W., Endres S. Endogenous adenosine curtails lipopolysaccharide-stimulated tumor necrosis factor synthesis. Scand J Immunol. 45:1997;132-139.
64. Ely S.W., Berne R.M. Protective effects of adenosine in myocardial ischemia. Circulation. 85:1992;893-904.
65. Ethier M.F., Chander V., Dobson J.G. Jr. Adenosine stimulates proliferation of human endothelial cells in culture. Am J Physiol. 265:1993;H131-H138.
66. Fenoglio C., Necchi D., Civallero M., Ceroni M., Nano R. Cytochemical demonstration of nitric oxide synthase and 5′ nucleotidase in human glioblastoma. Anticancer Res. 17:1997;2507-2511.
67. Finegan B.A., Lopaschuk G.D., Gandhi M., Clanachan A.S. Inhibition of glycolysis and enhanced mechanical function of working rat hearts as a result of adenosine A1 receptor stimulation during reperfusion following ischemia. Br J Pharmacol. 118:1996;355-363.
68. Firestein G.S., Boyle D., Bullough D.A., Gruber H.E., Sajjadi F.G., Montag A., Sambol B., Mullane K.M. Protective effect of an adenosine kinase inhibitor in septic shock. J Immunol. 152:1994;5853-5859.
69. Firestein G.S., Bullough D.A., Erion M.D., Jimenez R., Ramirez-Weinhouse M., Barankiewicz J., Smith C.W., Gruber H.E., Mullane K.M. Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins. J Immunol. 154:1995;326-334.
70. Fleischer B. CD26. a surface protease involved in T-cell activation Immunol Today. 15:1990;180-184.
71. Flocke K., Mannherz H.G. Isolation and characterization of 5′-nucleotidase of a human pancreatic tumor cell line. Biochim Biophys Acta. 1076:1991;273-281.
72. Fukunaga Y., Evans S.S., Yamamoto M., Ueda Y., Tamura K., Takakuwa T., Gebhard D., Allopenna J., Demaria S., Clarkson B., Thompson L.F., Safai B., Evans R.L. Increased density of ecto 5′ nucleotidase antigen on leukemic T cells from patients with cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. Blood. 74:1989;2486-2492.
73. Gadangi P., Longaker M., Naime D., Levin R.I., Trecht P.A., Montesinos M.C., Buckley M.T., Carlin G., Cronstein B.N. The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. J Immunol. 156:1996;1937-1941.
74. Garvey E.P., Lowen G.T., Almond M.R. Nucleotide and nucleoside analogues as inhibitors of cytosolic 5′-nucleotidase I from heart. Biochemistry. 37:1998;9043-9051.
75. Goldfeld A.E., Flemington E.K., Boussiotis V.A., Theodos C.M., Titus R.G., Strominger J.L., Speck S.H. Transcription of the tumor necrosis factor-alpha gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin-a and FK506 in human b-cells. Proc Natl Acad Sci USA. 89:1992;12198-12201.
76. Grant M.B., Tarnuzzer R.W., Caballoro S., Dzeck M.J., Davis M.I., Spoerri P.E., Feoktistov I., Biagioni I., Shryock J.C., Belardinelli L. Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ Res. 85:1999;699-706.
77. Griffiths E.J., Halestrap A.P. Protection by cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol. 25:1993;1461-1469.
78. Gutensohn W., Thiel E., Emmerich B. Evaluation of 5′-nucleotidase as biochemical marker in leukemias and lymphomas. Klin Wochenschr. 61:1983;57-62.
79. Handschin J.C., Eppenberger U. Altered cellular ratio of type I and type II cyclic AMP-dependent protein kinase in human mammary tumors. FEBS Lett. 106:1979;301-304.
80. Hasko G., Szabo C., Nemeth Z.H., Kvetan V., Pastores S.M., Vizi E.S. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol. 157:1996;4634-4640.
81. Hazama A., Hayashi S., Okada Y. Cell surface measurements of ATP release from single pancreatic beta cells using a novel biosensor technique. Pflügers Arch. 437:1998;31-35.
82. Headrick J.P., Willis R.J. 5′-Nucleotidase activity and adenosine formation in stimulated, hypoxic and underperfused rat heart. Biochem J. 261:1989;541-550.
83. Herbschleb-Voogt E., Ten Kate J., Meera Khan P. Adenosine deaminase complexing protein (ADCP). a transformation sensitive protein with potentials of a cancer marker Anticancer Res. 3:1983;95-100.
84. Hershfield M.S., Mitchell B.S. Immunodeficiency disease caused by adenosine deaminase deficiency and purine phosphorylase deficiency. Sriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Bases of Inherited Disease. 1995;1725-1768 McGraw-Hill, New York.
85. Heurteaux C., Lauritzen I., Widmann C., Lazdunski M. Essential role of adenosine A1 receptors, and ATP-sensitive K channels in cerebral ischemic preconditioning. Proc Natl Acad Sci USA. 92:1995;4666-4670.
86. Huang S., Apasov S., Koshiba M., Sitkovsky M. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood. 90:1997;1600-1610.
87. Hugo F., Mazurek S., Zander U., Eigenbrodt E. In vitro effect of extracellular AMP on MCF-7 breast cancer cells. inhibition of glycolysis and cell proliferation J Cell Physiol. 153:1992;539-549.
88. Janier M.F., Vanoverschelde J.J., Bergmann S.R. Adenosine protects ischemic and reperfused myocardium by receptor-mediated mechanism. Am J Physiol. 264:1993;H163-H170.
89. Jiang N., Kowaluk E.A., Lee C.H., Mazdiyasni H., Chopp M. Adenosine kinase inhibition protects brain against transient focal ischemia in rats. Eur J Pharmacol. 320:1997;131-137.
90. Kammer G.M., Boehm C.A., Rudolph S.A. Role of adenylate cyclase in human T-lymphocyte surface antigen capping. Cell Immunol. 101:1986;251-258.
91. Karasaki S., Suh M.H., Salas M., Raymond J. Cell surface adenosine 5′-triphosphatase as an in vitro marker of the lineage and cytodifferentiation of oncogenic epithelial cells from rat liver parenchyma. Cancer Res. 40:1980;1318-1328.
92. Katsuragi T., Tokunaga T., Ogawa S., Soejima O., Sato C., Furukawa T. Existence of ATP-evoked ATP release system in smooth muscles. J Pharmacol Exp Ther. 259:1991;513-518.
93. Kawano K., Kim Y.I., Kaketani K., Kobayashi M. The beneficial effect of cyclosporine on liver ischemia in rats. Transplantation. 48:1989;759-764.
94. Keil G.J., DeLander G.E. Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice. Eur J Pharmacol. 271:1994;37-46.
95. Khoo H.E., Ho C.L., Chhatwal V.J., Chan S.T., Ngoi S.S., Moochhala S.M. Differential expression of adenosine A1 receptors in colorectal cancer and related mucosa. Cancer Lett. 106:1996;17-21.
96. Kitakaze M., Hori M., Takashima S., Sato H., Inoue M., Kamada T. Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs - implications for myocardial salvage. Circulation. 87:1993;208-215.
97. Kitakaze M., Hori M., Morioka T., Minamino T., Takashima S., Okazaki Y., Node K., Komamura K., Iwakura K., Itoh T., Inoue M., Kamada T. Alpha 1-adrenoceptor activation increases ecto-5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation. 91:1995;2226-2234.
98. Kitakaze M., Minamino T., Node K., Komamura K., Inoue M., Hori M., Kamada T. Activation of ecto-5′-nucleotidase by protein kinase C attenuates irreversible cellular injury due to hypoxia and reoxygenation in rat cardiomyocytes. J Mol Cell Cardiol. 28:1996;1945-1955. a.
99. Kitakaze M., Node K., Minamino T., Komamura K., Funaya H., Shinozaki Y., Chujo M., Mori H., Inoue M., Hori M., Kamada T. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidase. Circulation. 93:1996;781-791. b.
100. Kittel A., Bacsy E. Ecto-ATPases and 5′-nucleotidases in the caveolae of smooth muscle. Enzyme-histochemical evidence may indicate a role for caveolae in neurotransmission. Cell Biol Int. 18:1994;875-879.
101. Knowles A.F. The rat liver ecto-ATPase/C-CAM cDNA detects induction of carcinoembryonic antigen but not the mercurial-insensitive ecto-ATPase in human hepatoma Li-7A cells treated by epidermal growth factor and cholera toxin. Biochem Biophys Res Commun. 207:1995;529-535.
102. Kohring K., Zimmermann H. Upregulation of ecto-5′-nucleotidase in human neuroblastoma SH-SY5Y cells on differentiation by retinoic acid and phorbol ester. Neurosci Lett. 258:1998;127-130.
103. Kojima O., Majima T., Uehara Y., Yamane T., Fujita Y., Takahashi T., Majima S. Alteration of adenosine deaminase levels in peripheral blood lymphocytes of patients with gastric cancer. Jpn J Surg. 15:1985;130-133.
104. Komoszynski M., Wojtczak A. Apyrases (ATP diphosphohydrolases, EC 3.6.1.5). function and relationship to ATPases Biochim Biophys Acta. 1310:1996;233-241.
105. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a beta-Catenin-Tcf complex in APC-/- colon carcinoma. Science. 275:1997;1784-1787.
106. Lappin D., Whaley K. Adenosine A2 receptors on human monocytes modulate C2 production. Clin Exp Immunol. 57:1984;454-456.
107. Ledoux S., Leroy C., Siegfried G., Prie D., Moullier P., Friedlander G. Overexpression of ecto-5′-nucleotidase promotes P-glycoprotein expression in renal epithelial cells. Kidney Int. 52:1997;953-961.
108. Lelievre V., Muller J.M., Falcon J. Adenosine modulates cell proliferation in human colonic adenocarcinoma. I. Possible involvement of adenosine A1 receptor subtypes in HT29 cells. Eur J Pharmacol. 341:1998;289-297. a.
109. Lelievre V., Muller J.M., Falcon J. Adenosine modulates cell proliferation in human colonic carcinoma. II. Differential behavior of HT29, DLD-1, Caco-2 and SW403 cell lines. Eur J Pharmacol. 341:1998;299-308. b.
110. Le Moine O., Stordeur P., Schandene L., Marchant A., de Groote D., Goldman M., Deviere J. Adenosine enhances IL-10 secretion by human monocytes. J Immunol. 156:1996;4408-4414.
111. Lin H.-Y., Fox I.H., Spychala J. ATP degradation and depletion of adenine nucleotides. Zelenock G.B. Clinical Ischemic Syndromes. Mechanism and Consequences of Tissue Injury. 1990;159-186 The C.V. Mosby Company, St. Louis.
112. Lin S.-H. Liver plasma membrane ecto-ATPase. purification, localization, cloning and function Ann N Y Acad Sci. 603:1990;394-400.
113. Lloyd H.G., Fredholm B.B. Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices. Neurochem Int. 26:1995;387-395.
114. Lode H.L., Xiang R., Becker J.C., Gilles S.D., Reisfeld R.A. Immunocytokines. a promising approach to cancer immunotherapy Pharmacol Ther. 80:1998;277-292.
115. Ludwig H.C., Rausch S., Schallock K., Markakis E. Expression of CD73 (ecto-5′-nucleotidase) in 165 glioblastoma by immunohistochemistry and electromicroscopic histochemistry. Anticancer Res. 19:1999;1747-1752.
116. Lutty G.A., Mathews M.K., Merges C., McLeod D.S. Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation. Curr Eye Res. 17:1998;594-607.
117. Ma D.D.F., Sylwestrowicz T., Janossy G., Hoffbrand A.V. The role of purine metabolic enzymes and terminal deoxynucleotidyl transferase in intrathymic T-cell differentiation. Immunol Today. 4:1983;65-68.
118. MacKenzie W.M., Hoskin D.W., Bly J. Adenosine inhibits the adhesion of anti-CD3-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor. Cancer Res. 54:1994;3521-3526.
119. Madrid-Marina V., Martinez-Valdez H., Cohen A. Phorbol esters induce changes in adenosine deaminase, purine nucleoside phosphorylase, and terminal deoxynucleotidyl transferase messenger RNA levels in human leukemic cell lines. Cancer Res. 50:1990;2891-2894.
120. Martinez-Valdez H., Cohen A. Coordinate regulation of mRNAs encoding adenosine deaminase, purine nucleoside phosphorylase, and terminal deoxynucleotidyltransferase by phorbol esters in human thymocytes. Proc Natl Acad Sci USA. 85:1988;6900-6903.
121. Mazurek S., Michel A., Eigenbrodt E. Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates. J Biol Chem. 27:1997;4941-4952.
122. McNally T., Helfrich R.J., Cowart M., Dorwin S.A., Meuth J.L., Idler K.B., Klute K.A., Simmer R.L., Kowaluk E.A., Halbert D.N. Cloning and expression of the adenosine kinase gene from rat and human tissues. Biochem Biophys Res Commun. 231:1997;645-650.
123. McWhinney C.D., Dudley M.W., Bowlin T.L., Peet N.P., Schook L., Bradshaw M., De M., Borcherding D.R., Edwards C.K. 3rd. Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-alpha. Eur J Pharmacol. 310:1996;209-216.
124. Meininger C.J., Granger H.J. Mechanisms leading to adenosine-stimulated proliferation of microvascular endothelial cells. Am J Physiol. 258:1990;H198-H206.
125. Miescher S., Whiteside T.L., Moretta L., Von Fliedner V. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors. J Immunol. 138:1987;4004-4011.
126. Minev B.R., Chavez F.L., Mitchell M.S. Cancer vaccines. novel approaches and new promise Pharmacol Ther. 81:1999;121-139.
127. Mitchell C.H., Carre D.A., McGlinn A.M., Stone R.A., Civan M.M. A release mechanism for stored ATP in ocular ciliary epithelial cells. Proc Natl Acad Sci USA. 95:1998;7174-7178.
128. Mitchell C.H., Peterson-Yantorno K., Carre D.A., McGlinn A.M., Coca-Prados M., Stone R.A., Civan M.M. A3 adenosine receptors regulate Cl- channels of nonpigmented ciliary epithelial cells. Am J Physiol. 276:1999;C659-C666.
129. Morrison M., Vijayasaradhi S., Engelstein D., Albino A., Houghton A. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J Exp Med. 177:1993;1135-1143.
130. Namiot Z., Stasiewicz J., Namiot A., Kemona A., Kralisz M., Gorski J. Adenosine deaminase activity in patients with the intestinal type of gastric carcinoma. Cancer Lett. 109:1996;199-202.
131. Natori Y., Baba T., Moriguchi M., Takeshita I., Fukui M. Effects of theophylline on the selective increases in intratumoral blood flow induced by intracarotid infusion of adenosine and adenosine triphosphate in C6 glioma-transplanted rat brains. Surg Neurol. 37:1992;8-14.
132. Newby A.C., Worku Y., Meghji P., Nakazawa M., Skladanowski A.C. Adenosine. a retaliatory metabolite or not? News Physiol Sci. 5:1990;67-70.
133. Nishinaka Y., Sugiyama S., Yokota M., Saito H., Ozawa T. Protective effect of FK506 on ischemia/reperfusion-induced myocardial damage in canine heart. J Cardiovasc Pharmacol. 21:1993;448-454.
134. Nyce J.W., Metzger W.J. DNA antisense therapy for asthma in an animal model. Nature. 385:1997;721-725.
135. Pak M.A., Haas H.L., Decking U.K., Schrader J. Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices. Neuropharmacology. 33:1994;1049-1053.
136. Parmely M.J., Zhou W.W., Edwards C.K. 3rd., Borcherding D.R., Silverstein R., Morrison D.C. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J Immunol. 151:1993;389-396.
137. Piroli G., Weisenberg L.S., Grillo C., De Nicola A.F. Subcellular distribution of cyclic adenosine 3′-5′-monophosphate-binding protein and estrogen receptors in control pituitaries and estrogen-induced pituitary tumors. J Natl Cancer Inst. 82:1990;596-601.
138. Porat N., Gill D., Parola A.H. Adenosine deaminase in cell transformation. Biophysical manifestation of membrane dynamics. J Biol Chem. 263:1988;14608-14611.
139. Poulsen S.A., Quinn R.J. Adenosine receptors. new opportunities for future drugs Bioorg Med Chem. 6:1998;619-641.
140. Prager M.D., Kanar M.C. Effect of dimethylsulfoxide and butyrate on 5′-nucleotidase of human renal carcinoma cells. Cancer Lett. 24:1984;81-88.
141. Prat A.G., Reisin I.L., Ausiello D.A., Cantiello H.F. Cellular ATP release by the cystic fibrosis transmembrane conductance regulator. Am J Physiol. 270:1996;C538-C545.
142. Pueyo M.E., Chen Y., D'Angelo G., Michel J.B. Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells. Exp Cell Res. 238:1998;354-358.
143. Rajpert E.J., Lemaigre F.P., Eliard P.H., Lace M., Lafontaine D.A., Economidis I.V., Belayev A., Martial J.A., Rousseau G.G. Glucocorticoid receptors bound to the antagonist RU486 are not downregulated despite their capacity to interact in vitro with defined gene regions. J Steroid Biochem. 26:1987;513-520.
144. Rapaport E. Anticancer activities of adenine nucleotides in tumor bearing hosts. Drug Dev Res. 28:1993;428-431.
145. Rathbone M.P., Middlemis P.J., Kim J.-K., Gysbers J.W., DeForge S.P., Smith R.W., Hughes D.W. Adenosine and its nucleotides stimulate proliferation of chick astrocytes and human astrocytoma cells. Neurosci Res. 13:1992;1-17.
146. Resnick M.B., Colgan S.P., Patapoff T.W., Mrsny R.J., Awtrey C.S., Delp-Archer C., Weller P.F., Madara J.L. Activated eosinophils evoke chloride secretion in model intestinal epithelia primarily via regulated release of 5′-AMP. J Immunol. 151:1993;5716-5723.
147. Richards G., Waas W., Kranzhofer R., Mayer E., Schomig A. Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart. a protective mechanism in early ischemia Circ Res. 61:1987;117-123.
148. Richardson P.J., Brown S.J., Bailyes E.M., Luzio J.P. Ectoenzymes control adenosine modulation of immunoisolated cholinergic synapses. Nature. 327:1987;232-234.
149. Rosengren S., Bong G.W., Firestein G.S. Anti-Inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage. J Immunol. 154:1995;5444-5451.
150. Rubinfeld B., Robbins P., El-Gamil M., Albert I., Porfiri E., Polakis P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science. 275:1997;1790-1792.
151. Rudolphi K.A., Schubert P., Parkinson F.E., Fredholm B.B. Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol Sci. 13:1992;439-445.
152. Rynning S.E., Brunvand H., Birkeland S., Hexeberg E., Grong K. Endogenous adenosine attenuates myocardial stunning by antiadrenergic effects exerted during ischemia and not during reperfusion. J Cardiovasc Pharmacol. 25:1995;432-439.
153. Sajjadi F.G., Takabayashi K., Foster A.C., Domingo R.C., Firestein G.S. Inhibition of TNF-alpha expression by adenosine. role of A3 adenosine receptors J Immunol. 156:1996;3435-3442.
154. Sala-Newby G.B., Skladanowski A.C., Newby A.C. The mechanism of adenosine formation in cells. Cloning of cytosolic 5′-nucleotidase-I. J Biol Chem. 274:1999;17789-17793.
155. Savic V., Stefanovic V., Ardaillou N., Ardaillou R. Induction of ecto-5′-nucleotidase of rat cultured mesangial cells by interleukin-1beta and tumor necrosis factor-alfa. Immunology. 70:1990;321-326.
156. Schoen S.W., Kreutzberg G.W. Synaptic 5′-nucleotidase activity reflects lesion-induced sprouting within the adult rat dentate gyrus. Exp Neurol. 127:1994;106-118.
157. Schoen S.W., Graeber M.B., Toth L., Kreutzberg G.W. Synaptic 5′-nucleotidase is transient and indicative of climbing fiber plasticity during the postnatal development of rat cerebellum. Dev Brain Res. 61:1991;125-138.
158. Schrader J. Adenosine. A homeostatic metabolite in cardiac energy metabolism. Circulation. 81:1990;389-391.
159. Schwiebert E.M., Egan M.E., Hwang T.H., Fulmer S.B., Allen S.S., Cutting G.R., Guggino W.B. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell. 81:1995;1063-1073.
160. Shi X.J., Knowles A.F. Prevalence of the mercurial-sensitive EctoATPase in human small cell lung carcinoma. characterization and partial purification Arch Biochem Biophys. 315:1994;177-184.
161. Siegfried G., Vrtovsnik F., Prie D., Amiel C., Friedlander G. Parathyroid hormone stimulates ecto-5′-nucleotidase activity in renal epithelial cells. role of protein kinase-C Endocrinology. 136:1995;1267-1275.
162. Snyder F.F., Lukey T. Kinetic considerations for the regulation of adenosine and deoxyadenosine metabolism in mouse and human tissues based on a thymocyte model. Biochim Biophys Acta. 696:1982;299-307.
163. Specchia G., Pavone V., Maggio F., Lojudice L., Iacobazzi A., De Tullio L., Cagnazzo G., Liso V. Adenosine deaminase activity in peripheral lymphocytes of patients with gynaecologic malignancies. Boll Ist Sieroter Milan. 64:1985;404-407.
164. Spielman W.S., Thompson C.I. A proposed role for adenosine in the regulation of renal hemodynamics and renin release. Am J Physiol. 242:1982;F423-F435.
165. Spychala J., Van den Berghe G. Adenine nucleotide metabolism in isolated chicken hepatocytes. Biochem J. 242:1987;551-558.
166. Spychala J., Datta N.S., Takabayashi K., Datta M., Fox I.H., Gribbin T., Mitchell B.S. Cloning of human adenosine kinase cDNA. sequence similarity to microbial ribokinases and fructokinases Proc Natl Acad Sci USA. 93:1996;1232-1237.
167. Spychala J., Mitchell B.S., Barankiewicz J. Adenosine metabolism during phorbol myristate acetate-mediated induction of HL-60 cell differentiation. changes in expression pattern of adenosine kinase, adenosine deaminase, and 5′-nucleotidase J Immunol. 158:1997;4947-4952.
168. Spychala J., Zimmermann A.G., Mitchell B.S. Tissue-specific regulation of the ecto-5′-nucleotidase promoter. role of the cAMP responsive element site in mediating repression by the upstream regulatory region J Biol Chem. 274:1999;22705-22712.
169. Szabo C., Scott G.S., Virag L., Egnaczyk G., Salzman A.L., Shanley T.P., Hasko G. Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol. 125:1998;379-387.
170. Tamesue S., Sato C., Katsuragi T. ATP release caused by bradykinin, substance P and histamine from intact and cultured smooth muscles of guinea-pig vas deferens. Naunyn Schmiedebergs Arch Pharmacol. 357:1998;240-244.
171. Taylor A.L., Kudlow B.A., Marrs K.L., Gruenert D.C., Guggino W.B., Schwiebert E.M. Bioluminescence detection of ATP release mechanisms in epithelia. Am J Physiol. 275:1998;C1391-C1406.
172. Thompson L.F., Saxon A., O'Connor R.D., Fox R.I. Ecto-5′-nucleotidase activity in human T cell subsets. J Clin Invest. 71:1983;892-899.
173. Thompson L.F., Ruedi J.M., O'Connor R.D., Bastia J.F. Ecto-5′-nucleotidase expression during human B cell development. An explanation for the heterogeneity in B lymphocyte ecto-5′-nucleotidase activity in patients with hypogammaglobulinemia. J Immunol. 137:1986;2496-2500.
174. Thompson L.F., Ruedi J.M., Glass A., Low M.G., Lucas A.H. Antibodies to 5′-nucleotidase (Cd73), a glycosyl-phosphatidylinositol-anchored protein, cause human peripheral blood T-cells to proliferate. J Immunol. 143:1989;1815-1821.
175. Trotta P.P., Balis M.E. Characterization of adenosine deaminase from normal colon and colon tumors. Evidence for tumor specific variants. Biochemistry. 17:1978;270-278.
176. Ujhazy P., Klobusicka M., Babusikova O., Strausbauch P., Mihich E., Ehrke M.J. Ecto-5′-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin. Int J Cancer. 59:1994;83-93.
177. Ujhazy P., Berleth E.S., Pietkiewicz J.M., Kitano H., Skaar J.R., Ehrke M.J., Mihich E. Evidence for the involvement of ecto-5′-nucleotidase (CD73) in drug resistance. Int J Cancer. 68:1996;493-500.
178. Velu T., Durez P., Van Mechelen M., Gerard C., Abramowicz D., Moser M., Leo O., Goldman M. In vivo induction of IL-10 by anti-CD3 monoclonal antibody in mice. Transplant Proc. 25:1993;568-569.
179. Vider B.Z., Zimber A., Chastre E., Prevot S., Gespach C., Estlein D., Wolloch Y., Tronick S.R., Gazit A., Yaniv A. Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. Oncogene. 12:1996;153-158.
180. Vigne P., Breittmayer J.P., Frelin C. Analysis of the influence of nucleotidases on the apparent activity of exogenous ATP and ADP at P2Y1 receptors. Br J Pharmacol. 125:1998;675-680.
181. Vogel M., Zimmermann H., Singer W. Transient association of the HNK-1 epitope with 5′-nucleotidase during development of the cat visual cortex. Eur J Neurosci. 5:1993;1423-1425.
182. Wenzel-Seifert K., Grunbaum L., Seifert R. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation. J Immunol. 147:1991;1940-1946.
183. Wesley U., Albino A., Tiwari S., Houghton A. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med. 190:1999;311-322.
184. Wiendl H.S., Schneider C., Ogilvie A. Nucleotide metabolizing ectoenzymes are upregulated in A431 cells periodically treated with cytostatic ATP leading to partial resistance without preventing apoptosis. Biochim Biophys Acta. 1404:1998;282-298.
185. Williams B.A., Manzer A., Blay J., Hoskin D.W. Adenosine acts through a novel extracellular receptor to inhibit granule exocytosis by natural killer cells. Biochem Biophys Res Commun. 231:1997;264-269.
186. Wilson P.D., Hovater J.S., Casey C.C., Fortenberry J.A., Schwiebert E.M. ATP release mechanisms in primary cultures of epithelia derived from the cysts of polycystic kidneys. J Am Soc Nephrol. 10:1999;218-229.
187. Wu P.H., Phillis J.W., Thierry D.L. Adenosine receptor agonists inhibit K-evoked and Ca uptake by rat brain cortical synaptosomes. J Neurochem. 39:1982;700-708.
188. Wyatt D.A., Edmunds M.C., Rubio R., Berne R.M., Lasley R.D., Mentzer R.M. Adenosine stimulates glycolytic flux in isolated perfused rat hearts by A-1-adenosine receptors. Am J Physiol. 257:1989;H1952-H1957.
189. 2B adenosine receptor expression in macrophages. a mechanism of macrophage deactivation J Immunol. 162:1999;3607-3614.
190. Yang S., Cheek D.J., Westfall D.P., Buxton I.L. Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. Circ Res. 74:1994;401-407.
191. Zhang X., Schiller G., Gill P., Coventry B.J. Lymphoid cell infiltration during breast cancer growth. a syngeneic rat model Immunol Cell Biol. 76:1998;550-556.
192. Zimmermann H. 5′-Nucleotidase. molecular structure and functional aspects Biochem J. 285:1992;345-365.
193. Zimmermann H. Two novel families of ectonucleotidases. molecular structures, catalytic properties and a search for function Trends Pharmacol Sci. 20:1999;231-236.